Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 24979-127

4 FDA label images from Upsher-smith Laboratories, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 24979-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tec00-0006-01 (Tec00 0006 01)

Tec00-0006-01 (Tec00 0006 01)
Chemical structure of dimethyl fumarate showing its molecular formula arrangement with functional groups, including ester and alkene components.*
FDA Label Image

Image Description (Dtfclinical)

Image Description (Dtfclinical)
A line graph showing the percentage of subjects with confirmed progression of disability over time in weeks up to 96 weeks. The chart compares placebo (n=408) and dimethyl fumarate delayed-release capsules 240 mg BID (n=409), indicating lower progression with the active drug compared to placebo. The vertical axis represents the percentage of subjects with disability progression, and the horizontal axis represents time on study in weeks.*
FDA Label Image

Image Description (Usl 120)

Image Description (Usl 120)
Label for Dimethyl Fumarate Delayed-Release Capsules, USP, 120 mg strength. The label indicates oral capsules in a 14-count package, distributed by Upsher-Smith Laboratories, LLC, Maple Grove, MN. It includes dosage instructions to swallow whole and take one capsule twice daily, storage conditions, and mentions color additives and manufacturing details.*
FDA Label Image

Image Description (Usl 240)

Image Description (Usl 240)
Drug facts panel for dimethyl fumarate delayed-release capsules, 240 mg, USP. The label details dosage instructions, storage conditions, color additives, distributor information (Upsher-Smith Laboratories, LLC), manufacturing location (Taiwan), and packaging quantity (60 capsules). Includes barcode and revision date 11/2024.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.